RxDoctor Payments DataLook up a doctor →

Vincenzo Galati, DO

Urology · Cape Girardeau, MONPI 1376693754

Payments from drug & device makers

$9,097in general payments, 2019–2025

Across 352 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$2K
  • Astellas Pharma US Inc$1K
  • AbbVie$810
  • Medtronic$661
  • EDAP Technomed Inc$432
  • Merck$399
  • plus $4K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teleflex LLC18$1,578
Astellas Pharma US Inc75$1,131
AbbVie(2 entities)57$810
Medtronic15$661
EDAP Technomed Inc3$432
Merck23$399
Boston Scientific15$331
Myriad Genetic Laboratories, Inc.8$327
Pfizer15$281
Dendreon Pharmaceuticals LLC8$275
Johnson & Johnson(2 entities)9$249
Bayer5$210
Angiodynamics, Inc.2$171
Urogen Pharma, Inc.10$170
Procept Biorobotics Corporation2$162
Coloplast9$161
Rochester Medical Corporation6$135
C. R. Bard, Inc. & Subsidiaries3$129
Blue Earth Diagnostics6$125
Ferring Pharmaceuticals Inc.5$122
Amgen6$121
Myovant Sciences Inc.6$114
Novartis4$95
Travere Therapeutics, Inc.4$81
Intuitive Surgical1$69
Innovation Technologies Inc1$69
Endo USA, Inc.3$66
Sumitomo Pharma America, Inc.3$64
Axonics, Inc.3$64
Calyxo, Inc.3$63
Neotract Inc.3$47
Sanofi2$47
Olympus America Inc.2$31
Tolmar, Inc.2$31
Laborie Medical Technologies Corp.2$30
Cumberland Pharmaceuticals, Inc.2$28
AstraZeneca1$25
Progenics Pharmaceuticals, Inc.1$25
Otsuka America Pharmaceutical, Inc.1$25
Cook Medical LLC1$24
Pacira Pharmaceuticals Incorporated1$22
Telix Pharmaceuticals1$19
Vertex1$18
Zyla Life Sciences, Inc.1$17
Alnylam Pharmaceuticals Inc.1$16
Caris MPI, Inc.1$15
Bristol Myers Squibb1$14

How this compares

$9,097 in reported general payments places this provider in the 75th percentile of 250 urology providers in Missouri.

See all urology providers in Missouri →

Medicare billing

Part B allowed, 2024
$353,115
Medicare patients
712
Services billed
10,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Cape Girardeau

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →